Well they are patenting the individual peptides they discover, so they are likely to have a huge library of monopoly peptides. Perhaps they can corner the canc

Well they are patenting the individual peptides they discover, so they are likely to have a huge library of monopoly peptides. Perhaps they can corner the cancer market and still make a $trillion while lowering costs per patient too. Peptides are very cheap to produce.